Gender Differences in Clinical Manifestations of Brugada Syndrome
Begoña Benito, MD*,
Andrea Sarkozy, MD ,
Lluis Mont, MD, PhD*,
Stephan Henkens, RN ,
Antonio Berruezo, MD*,
David Tamborero, BEng*,
Dabit Arzamendi, MD*,
Paola Berne, MD*,
Ramon Brugada, MD, PhD ,
Pedro Brugada, MD, PhD and
Josep Brugada, MD, PhD*,*
* Cardiology Department, The Thorax Institute, Hospital Clínic, University of Barcelona, Barcelona, Spain
Heart Rhythm Management Centre, Cardiovascular Institute, UZ Brussel, VUB Brussels, Belgium
Cardiovascular Genetics Center, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada

View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Estimate of Cardiac Event-Free Survival According to Gender
Kaplan-Meier analysis of cardiac events in follow-up, defined as sudden cardiac death (SCD) or documented ventricular fibrillation (VF), in male and female patients.
|
|
|